经尿道等离子前列腺电切术对良性前列腺增生的疗效评估

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (42 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the effects of transurethral resection of prostate on intraoperative blood loss，therapeutic effect and postoperative complications of patients with benign prostatic hyperplasia(BPH).MethodsThe clinical data of 80 cases of patients with benign prostatic hyperplasia in our hospital from January 2015 to January 2017 were retrospectively analyzed，these patients were divided into TURP group(study group，n=40)and open surgical gland resection group（control group，n=40)two groups according to the treatment methods，the operation time，intraoperative blood loss，indwelling catheter time，IPSS scores，Qmax，RUV，QOL scores，therapeutic effects，postoperative complications of the two groups were statistically analyzed.ResultsThe operation time，indwelling catheter time of the study group were significantly shorter(P＜0.05)，the intraoperative blood loss was significantly less(P＜0.05)，the IPSS score，RUV were significantly lower(P＜0.05)，the Qmax，QOL score were significantly higher(P＜0.05)，the total treatment efficiency [92.5%(37/40)]was significantly higher than that of the control group[75.0%(30/40)](P＜0.05)，the postoperative complications rate[17.5%(7/40)]was significantly lower than that of the control group[35.0%(14/40)](P＜0.05).ConclusionTransurethral resection of prostate is more effective in reducing the intraoperative blood loss，improving the therapeutic effect，reduce the postoperative complications of patients with benign prostatic hyperplasia than open surgical gland resection.

Key words： Transurethral resection of prostate Benign prostatic hyperplasia Intraoperative blood loss Therapeutic effect Ostoperative complications

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I19/61

[3]	罗伟聪．经尿道电切术治疗前列腺增生症56例临床观察[J]．当代医学，2013，19（21）：92-93．
[4]	成泽民，杜义堂，曾东升，等．经尿道前列腺电切术对高龄高危前列腺增生症患者生活质量的影响[J]．重庆医学，2010，39（9）：1100-1101．
[5]	黄秋明，廖石刚，王琼．经尿道电切术治疗前列腺增生症的临床效果观察[J]．中国医药指南，2011，9（18）：122-123．
[6]	刘斐．经尿道前列腺电切术对高危良性前列腺增生症患者生活质量的影响[J]．中国医学创新，2012，9（13）：38-39．
[1]	魏其琛，程晖．经尿道前列腺电切术236例诊治体会[J]．福建医药杂志，2013，35（3）：42．
[2]	代宏，王春梅．经尿道电切术治疗高龄高危前列腺增生患者的临床观察[J]．海南医学院学报，2012，18（7）：919-920．
[7]	曾明祥．经尿道电切术治疗前列腺增生症的临床疗效观察[J]．当代医学，2013，19（1）：102-103．
[8]	廖伟强，罗立旷．经尿道前列腺电切术1370例手术体会[J]．中华腔镜泌尿外科杂志（电子版），2014，8（2）：36-37．
[9]	方雪峰，吴圣杰，黄朝荣，等.经尿道前列腺电切术后尿道狭窄的原因分析及对策[J].中国社区医师，2011，13（26）：97-98.
[10]	张军．经尿道前列腺电切术治疗良性前列腺增生的效果分析[J]．中外医学研究，2013，11（34）：129．
[11]	李学成.两种手术方法治疗良性前列腺增生的疗效比较[J].当代医学，2012，18（4）：75-76.
[12]	王维帅.经尿道前列腺电切术对良性前列腺增生患者的疗效及生活质量的影响[J].中国现代医生，2015，53（3）：38-40.
[13]	吴波，杨波，周东言，等.经尿道前列腺等离子双极电切术与耻骨上经膀胱前列腺切除术治疗良性前列腺增生的疗效和安全性比较[J].中国现代医生，2014，20（28）：24-26.
[14]	Rajnish K，Pankaj C，Priyanka M，et al.Synthesis，biological evaluation and in silico studies of novel 5α-aza-bhomo-3，5-secosteroids as potential 5-reductase inhibitors[J].Drug Des Devel Ther，2016，13（9）：869-878.
[15]	Osama E，Naira M，Joanna S，et al.Differentiating transition zone cancers from benign prostatic hyperplasia by quantitative multiparametric magnetic resonance imaging[J].J Comput Assist Tomogr，2016，40（2）：218-224.
[16]	Marisa C，Araceli SM，Mariana G，et al.Recent advances in drug design and drug discovery for androgen-dependent diseases[J].Curr Med Chem，2016，23（8）：792-815.
[17]	Luisella P，Petros S，Pietro C，et al.Current pharmacological treatment for male LUTS due to BPH：dutasteride or finasteride?[J].Curr Drug Targets，2015，16（11）：1165-1171.
[18]	Claus GR，Igor OP，Erik PMR，et al.Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment?A post hoc analysis of data from the 2-year CONDUCT study[J].World J Urol，2017，5（3）：421-427.
[19]	Petros S，Stavros G.The impact of combination therapy with a-blockers and 5ARIs on the progression of BPH[J].Curr Drug Targets，2015，16（11）：1172-1179.
[20]	Sonal G，Gopal G，Sharma V.L.Evolving novel chemical entities for management of benign prostatic hyperplasia[J].Mini Rev Med Chem，2017，17（7）：593-602.（收稿日期：2017-04-19本文编辑：崔建中）